CD34 and leukemia: ARV-825 resulted in reduced BETP-dependent transcription of chemokine receptors, indicated by downregulation of surface CXCR4 and CD44 in leukemia stem cell populations, thereby reducing CD34+CD38– putative leukemia progenitor cell populations without affecting healthy BM–derived progenitor cells [132].